AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Studies in Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Motor Neuron Disorders

Recruitingn/aAges 18 Years - anyAllMayo Clinic
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to collect, from patients with sporadic and familial ALS and their family members, clinical data and blood samples for extraction of DNA, RNA, preparation of lymphocytes, plasma and serum to establish a repository for future investigations of genetic contributions to ALS pathogenesis. Blood samples for DNA extraction also would be collected from control subjects with no personal or family history of ALS phenotypes.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria ALS or Suspected ALS Patient * Clinical diagnosis of possible, laboratory-supported probable, probable or definite ALS according to modified EL Escorial criteria, suspected ALS according to original El Escorial criteria, or diagnosis of a neurodegenerative disorder with evidence of ALS plus extramotor features; OR * Blood relative (first, second or third degree) with history of ALS or neurodegenerative disorder with evidence of ALS plus extramotor features; OR: * A clinical suspicion or referral for ALS; * \> 18 years of age; * Willing and able to give signed informed consent or assent that has been approved by the Institutional Review Board (IRB). Blood Relative of ALS Patient * Family history (first, second or third degree blood relative) of ALS or other motor neuron disease; * \> 18 years of age; * Willing and able to give signed informed consent that has been approved by the Institutional Review Board (IRB). Healthy Control * No personal or family history (first, second or third degree blood relative) of ALS or other motor neuron disease; * \> 18 years of age; * No personal history of other neurodegenerative disease (i.e., Alzheimer disease, Parkinson disease); * Willing and able to give signed informed consent that has been approved by the Institutional Review Board (IRB). Exclusion Criteria: ALS or Suspected Patient • Limited mental capacity rendering the subject unable to provide written informed consent or assent or comply with standard phlebotomy procedures. Blood Relative of ALS Patient • Limited mental capacity rendering the subject unable to provide written informed consent or comply with standard phlebotomy procedures. Healthy Control Subject * Personal or family history of dementia or other neurodegenerative disease (Parkinson disease, Alzheimer disease, etc.); * Limited mental capacity rendering the subject unable to provide written informed consent or comply with standard phlebotomy procedures.
💊

What it tests

  • Not listed
📍

Where

1 site
Mayo Clinic Florida
Jacksonville, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy